Gastroparesia y otros síntomas gastrointestinales en la enfermedad de Parkinson

Santos García, Diego; Deux, Teresa de; Tejera Pérez, Crisitina; Expósito Ruiz, Irene; Suárez Castro, Ester; Carpintero, Pedro; Macías Arribi, Mercedes.
Rev. neurol. (Ed. impr.) ; 61(6): 261-270, 16 sept., 2015. tab, ilus
Artículo en Español | IBECS (España) | ID: ibc-142562

Documentos relacionados

  1. Substantial Variability in Placebo and Nocebo Responses Challenges the Validity of Network Meta-Analysis of Gastroparesis Pharmacotherapy.
  2. Benefits of Prokinetics, Gastroparesis Diet, or Neuromodulators Alone or in Combination for Symptoms of Gastroparesis.
  3. White Paper AGA: Gastroparesis: Clinical and Regulatory Insights for Clinical Trials.
  4. SIALORRHEA AND XEROSTOMIA IN PARKINSON'S DISEASE PATIENTS.
  5. Updates in functional dyspepsia and bloating.
  6. A gluco-mindful approach to diabetic gastroparesis.
  7. Submandibular gland botulinum neurotoxin A injection for predicting the outcome of submandibular duct relocation in drooling: a retrospective cohort study.
  8. Migraine and Gastroparesis.
  9. Response and Adverse Event Rates With Placebo in Gastroparesis: A Systematic Review and Meta-analysis.
  10. Efficacy and Safety of Drugs for Gastroparesis: Dopamine Receptor Antagonists Should Not Be Considered as a Single Pharmacologic Entity.